{"title":"甲基强的松龙与地塞米松治疗Covid-19患者:一项已发表的临床试验分析","authors":"R. Pacheco, Hugo Mamede, D. Wiltgen, A. Stein","doi":"10.17267/2675-021xevidence.2021.e3814","DOIUrl":null,"url":null,"abstract":"How to cite this article: Pacheco RL, Mamede H, Wiltgen D, Stein A. Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial. J Évid-Based Healthc. 2021;3:e3814. http://dx.doi.org/10.17267/2675-021Xevidence.2021. e3814 Submitted 05/06/2021, Accepted 06/22/2021, Published 08/05/2021 J. Évid-Based Healthc., Salvador, 2021;3:e3814 http://dx.doi.org/10.17267/2675-021Xevidence.2021.e3814 ISSN: 2675-021X Assigned editor: Luis Claudio Correia Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial Critical Appraisal of Evidence","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":"59 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial\",\"authors\":\"R. Pacheco, Hugo Mamede, D. Wiltgen, A. Stein\",\"doi\":\"10.17267/2675-021xevidence.2021.e3814\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"How to cite this article: Pacheco RL, Mamede H, Wiltgen D, Stein A. Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial. J Évid-Based Healthc. 2021;3:e3814. http://dx.doi.org/10.17267/2675-021Xevidence.2021. e3814 Submitted 05/06/2021, Accepted 06/22/2021, Published 08/05/2021 J. Évid-Based Healthc., Salvador, 2021;3:e3814 http://dx.doi.org/10.17267/2675-021Xevidence.2021.e3814 ISSN: 2675-021X Assigned editor: Luis Claudio Correia Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial Critical Appraisal of Evidence\",\"PeriodicalId\":55996,\"journal\":{\"name\":\"International Journal of Evidence-Based Healthcare\",\"volume\":\"59 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Evidence-Based Healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17267/2675-021xevidence.2021.e3814\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Evidence-Based Healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17267/2675-021xevidence.2021.e3814","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial
How to cite this article: Pacheco RL, Mamede H, Wiltgen D, Stein A. Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial. J Évid-Based Healthc. 2021;3:e3814. http://dx.doi.org/10.17267/2675-021Xevidence.2021. e3814 Submitted 05/06/2021, Accepted 06/22/2021, Published 08/05/2021 J. Évid-Based Healthc., Salvador, 2021;3:e3814 http://dx.doi.org/10.17267/2675-021Xevidence.2021.e3814 ISSN: 2675-021X Assigned editor: Luis Claudio Correia Methylprednisolone versus dexamethasone for Covid-19 patients: an analysis of a published clinical trial Critical Appraisal of Evidence
期刊介绍：
The International Journal of Evidence-Based Healthcare is the official journal of the Joanna Briggs Institute. It is a fully refereed journal that publishes manuscripts relating to evidence-based medicine and evidence-based practice. It publishes papers containing reliable evidence to assist health professionals in their evaluation and decision-making, and to inform health professionals, students and researchers of outcomes, debates and developments in evidence-based medicine and healthcare.
The journal provides a unique home for publication of systematic reviews (quantitative, qualitative, mixed methods, economic, scoping and prevalence) and implementation projects including the synthesis, transfer and utilisation of evidence in clinical practice. Original scholarly work relating to the synthesis (translation science), transfer (distribution) and utilization (implementation science and evaluation) of evidence to inform multidisciplinary healthcare practice is considered for publication. The journal also publishes original scholarly commentary pieces relating to the generation and synthesis of evidence for practice and quality improvement, the use and evaluation of evidence in practice, and the process of conducting systematic reviews (methodology) which covers quantitative, qualitative, mixed methods, economic, scoping and prevalence methods. In addition, the journal’s content includes implementation projects including the transfer and utilisation of evidence in clinical practice as well as providing a forum for the debate of issues surrounding evidence-based healthcare.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
